Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response
Authors
Keywords
-
Journal
CELL RESEARCH
Volume 25, Issue 2, Pages 225-236
Publisher
Springer Nature
Online
2015-01-20
DOI
10.1038/cr.2015.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling
- (2013) Abderrahmane Kaidi et al. NATURE
- Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides
- (2013) Yung-Luen Yu et al. PLoS One
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Gefitinib Radiosensitizes Stem-Like Glioma Cells: Inhibition of Epidermal Growth Factor Receptor-Akt-DNA-PK Signaling, Accompanied by Inhibition of DNA Double-Strand Break Repair
- (2012) Khong Bee Kang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nuclear EGFR Suppresses Ribonuclease Activity of Polynucleotide Phosphorylase through DNAPK-mediated Phosphorylation at Serine 776
- (2012) Yung-Luen Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
- (2011) H. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- IKKα Activation of NOTCH Links Tumorigenesis via FOXA2 Suppression
- (2011) Mo Liu et al. MOLECULAR CELL
- More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance
- (2011) Jiri Lukas et al. NATURE CELL BIOLOGY
- Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF
- (2011) Hanna Björkelund et al. PLoS One
- Autophosphorylation and ATM Activation
- (2010) Sergei V. Kozlov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage Response
- (2010) Martin V. Bennetzen et al. MOLECULAR & CELLULAR PROTEOMICS
- Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
- (2010) Soo-Yeon Park et al. Molecular Cancer
- Nuclear trafficking of the epidermal growth factor receptor family membrane proteins
- (2010) Y-N Wang et al. ONCOGENE
- Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
- (2009) S.-C. Wang et al. CLINICAL CANCER RESEARCH
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- BRIT1/MCPH1 links chromatin remodelling to DNA damage response
- (2009) Guang Peng et al. NATURE CELL BIOLOGY
- Molecular therapy in head and neck oncology
- (2009) Jacques Bernier et al. Nature Reviews Clinical Oncology
- Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo
- (2008) Jeremy A. Daniel et al. JOURNAL OF CELL BIOLOGY
- Dancing on Damaged Chromatin: Functions of ATM and the RAD50/MRE11/NBS1 Complex in Cellular Responses to DNA Damage
- (2008) Kenta IIJIMA et al. JOURNAL OF RADIATION RESEARCH
- Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK
- (2008) Klaus Dittmann et al. Molecular Cancer
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression
- (2008) Liang-Yi Hung et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started